The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Features of Selective Kinase Inhibitors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Global analysis of protein expression in yeast
Ghaemmaghami, S., Huh, W.-K., Bower, K., Howson, R. W., Belle, A., Dephoure, N., O'Shea, E. K., & Weissman, J. S. (2003) · Nature · doi:10.1038/nature02046 · Cited by 3,750
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,015
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Physiological concentrations of purines and pyrimidines
Traut, T. W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928361 · Cited by 1,867
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494 · cited 1×
“Rapaycin acts by binding to the ubiquitously expressed rotein FKBP [84], and it is this rapamycin-FKBP comlex that binds to the FRB domain of mTOR [85, 86].”
BackgroundThe specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“Two valuable studies have profiled many of the most commonly used kinase inhibitors against 28 protein kinases in this way [62, 63].”
BackgroundProtein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Ultrasensitivity in the mitogen-activated protein kinase cascade.
Huang, C. Y., & Ferrell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10078 · Cited by 1,186
A chemical switch for inhibitor-sensitive alleles of any protein kinase
Bishop, A. C., Ubersax, J. A., Petsch, D. T., Matheos, D. P., Gray, N. S., Blethrow, J., Shimizu, E., Tsien, J. Z., Schultz, P. G., Rose, M. D., et al. (2000) · Nature · doi:10.1038/35030148 · Cited by 1,031
Self-citationNavigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice
Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D., et al. (2002) · Science · doi:10.1126/science.1073560 · Cited by 946
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 833
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Prieto, I., Odajima, J., Martín, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 796
Ohren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb859 · Cited by 626
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607
A Specific Mechanism of Nonspecific Inhibition
McGovern, S. L., Helfand, B. T., Feng, B., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030266r · Cited by 598
Ferrell, J. E. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)20026-x · Cited by 591
Burke, J. R., Pattoli, M. A., Gregor, K. R., Brassil, P. J., MacMaster, J. F., McIntyre, K. W., Yang, X., Iotzova, V. S., Clarke, W., Strnad, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209677200 · Cited by 550
Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.017 · Cited by 468
Fry, D. W., Bridges, A. J., Denny, W. A., Doherty, A., Greis, K. D., Hicks, J. L., Hook, K. E., Keller, P. R., Leopold, W. R., Loo, J. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.12022 · Cited by 418
Leahy, J. J. J., Golding, B. T., Griffin, R. J., Hardcastle, I. R., Richardson, C., Rigoreau, L., & Smith, G. C. M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.060 · Cited by 411
Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00522-8 · Cited by 401
BARNETT, S. F., DEFEO-JONES, D., FU, S., HANCOCK, P. J., HASKELL, K. M., JONES, R. E., KAHANA, J. A., KRAL, A. M., LEANDER, K., LEE, L. L., et al. (2005) · Biochemical Journal · doi:10.1042/bj20041140 · Cited by 396
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Synthetic small molecules that control stem cell fate
Ding, S., Wu, T. Y. H., Brinker, A., Peters, E. C., Hur, W., Gray, N. S., & Schultz, P. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0732087100 · Cited by 376
Noise amidst the silence: off-target effects of siRNAs?
Jackson, A. L., & Linsley, P. S. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.006 · Cited by 368
Jou, S.-T., Carpino, N., Takahashi, Y., Piekorz, R., Chao, J.-R., Carpino, N., Wang, D., & Ihle, J. N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8580-8591.2002 · Cited by 357
Privileged Molecules for Protein Binding Identified from NMR-Based Screening
Hajduk, P. J., Bures, M., Praestgaard, J., & Fesik, S. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000164q · Cited by 351
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., Salassidis, K., Stein-Gerlach, M., Missio, A., Cotten, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535024100 · Cited by 336
IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex
Mercurio, F., Murray, B. W., Shevchenko, A., Bennett, B. L., Young, D. B., Li, J. W., Pascual, G., Motiwala, A., Zhu, H., Mann, M., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1526 · Cited by 325
Zheng, X.-F., Fiorentino, D., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995) · Cell · doi:10.1016/0092-8674(95)90058-6 · Cited by 301
A Novel Method for Measurement of Submembrane ATP Concentration
Gribble, F. M., Loussouarn, G., Tucker, S. J., Zhao, C., Nichols, C. G., & Ashcroft, F. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001010200 · Cited by 279
Structural basis for selective inhibition of Src family kinases by PP1
Liu, Y., Bishop, A., Witucki, L., Kraybill, B., Shimizu, E., Tsien, J., Ubersax, J., Blethrow, J., Morgan, D. O., & Shokat, K. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80118-5 · Cited by 252
Self-citationThe pleitropic drug ABC transporters from Saccharomyces cerevisiae.
Rogers, B. L., Decottignies, A., Kołaczkowski, M., Carvajal, E., Balzi, E., & Goffeau, A. (2001) · PubMed · Cited by 243
Bypassing a Kinase Activity with an ATP-Competitive Drug
Papa, F. R., Zhang, C., Shokat, K., & Walter, P. (2003) · Science · doi:10.1126/science.1090031 · Cited by 235
Self-citationBisperoxovanadium compounds are potent PTEN inhibitors
Schmid, A. C., Byrne, R. D., Vilar, R., & Woscholski, R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.102 · Cited by 231
Kinase Inhibitors: Not Just for Kinases Anymore
McGovern, S. L., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020427b · Cited by 230
Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity.
Lowell, C. A., Soriano, P., & Varmus, H. E. (1994) · Genes & Development · doi:10.1101/gad.8.4.387 · Cited by 228
Liu, Y., Shreder, K. R., Gai, W., Corral, S., Ferris, D. K., & Rosenblum, J. S. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.009 · Cited by 209
Frantz, B., Klatt, T., Pang, M., Parsons, J., Rolando, A., Williams, H., Tocci, M. J., O'Keef, S. J., & O'Neill, E. A. (1998) · Biochemistry · doi:10.1021/bi980832y · Cited by 200
Yamamoto, N., Takeshita, K., Shichijo, M., Kokubo, T., Sato, M., Nakashima, K., Ishimori, M., Nagai, H., Li, Y.-F., Yura, T., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052316 · Cited by 190
Liu, Y., Kung, C., Fishburn, J., Ansari, A. Z., Shokat, K. M., & Hahn, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1721-1735.2004 · Cited by 185
Self-citationThe development and therapeutic potential of protein kinase inhibitors
Cohen, P. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80067-2 · Cited by 182
Kinomics—structural biology and chemogenomics of kinase inhibitors and targets
Vieth, M., Higgs, R. E., Robertson, D. H., Shapiro, M., Gragg, E. A., & Hemmerle, H. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.028 · Cited by 175
Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1
Murata, T., Shimada, M., Sakakibara, S., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01046-6 · Cited by 172
Chemical Genetic Analysis of Apg1 Reveals A Non-kinase Role in the Induction of Autophagy
Abeliovich, H., Zhang, C., Dunn, W. A., Shokat, K. M., & Klionsky, D. J. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0413 · Cited by 160
Self-citationIKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2
Kishore, N. N., Huynh, Q. K., Mathialagan, S., Hall, T., Rouw, S., Creely, D., Lange, G., Caroll, J., Reitz, B. A., Donnelly, A. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110474200 · Cited by 156
Wohlbold, L., van der Kuip, H., Miething, C., Vornlocher, H., Knabbe, C., Duyster, J., & Aulitzky, W. E. (2003) · Blood · doi:10.1182/blood-2002-12-3899 · Cited by 153
Blencke, S., Zech, B., Engkvist, O., Greff, Z., Őrfi, L., Horváth, Z., Kéri, G., Ullrich, A., & Daub, H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.029 · Cited by 152
Intracellular Targets of Paullones
Knockaert, M., Wieking, K., Schmitt, S., Leost, M., Grant, K. M., Mottram, J. C., Kunick, C., & Meijer, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202651200 · Cited by 144
Selective role of PI3Kδ in neutrophil inflammatory responses
Sadhu, C., Dick, K. O., Tino, W. T., & Staunton, D. E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01480-3 · Cited by 142
Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4p
Weiss, E. L., Bishop, A. C., Shokat, K. M., & Drubin, D. G. (2000) · Nature Cell Biology · doi:10.1038/35036300 · Cited by 140
Self-citationIsoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold
Knight, Z. A., Chiang, G. G., Alaimo, P. J., Kenski, D. M., Ho, C., Coan, K., Abraham, R. T., & Shokat, K. M. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.06.022 · Cited by 137
Self-citationKendall, R. L., Rutledge, R. Z., Mao, X., Tebben, A. J., Hungate, R. W., & Thomas, K. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6453 · Cited by 136
Murata, T., Shimada, M., Sakakibara, S., Yoshino, T., Masuda, T., Shintani, T., Sato, H., Koriyama, Y., Fukushima, K., Nunami, N., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.041 · Cited by 120
Discovery and Characterization of a Substrate Selective p38α Inhibitor
Davidson, W. C., Frego, L., Peet, G. W., Kroe‐Barrett, R., Labadia, M. E., Lukas, S., Snow, R. J., Jakes, S., Grygon, C. A., Pargellis, C., et al. (2004) · Biochemistry · doi:10.1021/bi0495073 · Cited by 119
Lowell, C., Niwa, M., Soriano, P. M., & Varmus, H. E. (1996) · Blood · doi:10.1182/blood.v87.5.1780.1780 · Cited by 118
Downing, G. J., Kim, S. E., Nakanishi, S., Catt, K. J., & Balla, T. (1996) · Biochemistry · doi:10.1021/bi9517493 · Cited by 116
Fraley, M. E., Hoffman, W. F., Rubino, R. S., Hungate, R. W., Tebben, A. J., Rutledge, R. Z., McFall, R. C., Huckle, W. R., Kendall, R. L., Coll, K. E., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00525-5 · Cited by 115
Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation
Lin, T.-A., McIntyre, K. W., Das, J., Liu, C., O'Day, K., Penhallow, B. A., Hung, C.-Y., Whitney, G. S., Shuster, D. J., Yang, X.-X., et al. (2004) · Biochemistry · doi:10.1021/bi049428r · Cited by 113
Brehmer, D., Godl, K., Zech, B., Wissing, J. B., & Daub, H. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300139-mcp200 · Cited by 106
On the Concentrations of Cyclins and Cyclin-Dependent Kinases in Extracts of Cultured Human Cells
Arooz, T., Yam, C. H., Siu, W. Y., Lau, A. W. S., Li, K. K. W., & Poon, R. Y. C. (2000) · Biochemistry · doi:10.1021/bi0009643 · Cited by 100
Arnold, L. D., Calderwood, D. J., Dixon, R. W., Johnston, D. N., Kamens, J., Munschauer, R., Rafferty, P., & Ratnofsky, S. E. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00441-8 · Cited by 93
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
Baxter, A., Brough, S., Cooper, A. E., Floettmann, E., Foster, S., Harding, C. J., Kettle, J. G., McInally, T., Martin, C., Mobbs, M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.058 · Cited by 89
Protein tyrosine phosphatases in T cell physiology
Mustelin, T., Alonso, A., Bottini, N., Huynh, H., Rahmouni, S., Nika, K., Louis-Dit-Sully, C., Tautz, L., Togo, S. H., Bruckner, S. R., et al. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.015 · Cited by 89
Tengholm, A., & Meyer, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01223-x · Cited by 86
Wissing, J. B., Godl, K., Brehmer, D., Blencke, S., Weber, M., Habenberger, P., Stein-Gerlach, M., Missio, A., Cotten, M. L., Müller, S., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400124-mcp200 · Cited by 86
Parast, C. V., Mroczkowski, B., Pinko, C., et al. (1998) · Biochemistry · doi:10.1021/bi981291f · Cited by 75
Martin, J. W., Avkiran, M., Quinlan, R. A., Cohen, P., & Marber, M. S. (2001) · Circulation Research · doi:10.1161/hh2101.099504 · Cited by 75
Recombinant IκB Kinases α and β Are Direct Kinases of IκBα
Li, J., Peet, G. W., Pullen, S. S., Schembri-King, J., Warren, T. C., Marcu, K. B., Kehry, M. R., Barton, R. W., & Jakes, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30736 · Cited by 72
Wong, S., McLaughlin, J., Cheng, D., Zhang, C., Shokat, K. M., & Witte, O. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407061101 · Cited by 72
Self-citationRosania, G. R., Merlie, J. P., Gray, N. S., Chang, Y., Schultz, P. G., & Heald, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4797 · Cited by 67
Characterization of the Recombinant IKK1/IKK2 Heterodimer
Huynh, Q. K., Boddupalli, H., Rouw, S., Koboldt, C. M., Hall, T., Sommers, C., Hauser, S. D., Pierce, J. L., Combs, R. G., Reitz, B. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000296200 · Cited by 66
p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol
Knockaert, M., Lenormand, P., Gray, N. S., Schultz, P. G., Pouysségur, J., & Meijer, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205908 · Cited by 64
Toward a Pharmacophore for Kinase Frequent Hitters
Aronov, A. M., & Murcko, M. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049793g · Cited by 60
Chong, Y., Mulhern, T. D., Zhu, H., Fujita, D. J., Bjorge, J. D., Tantiongco, J.-P., Sotirellis, N., Lio, D. S. S., Scholz, G. M., & Cheng, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309865200 · Cited by 59
Molecularly Targeted Therapy: Have the Floodgates Opened?
Druker, B. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-357 · Cited by 59
A Kinase-Independent Function of Cks1 and Cdk1 in Regulation of Transcription
Yu, V. P. C. C., Baskerville, C., Grünenfelder, B., & Reed, S. I. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.020 · Cited by 54
Hardy, L. W., & Peet, N. P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02969-6 · Cited by 51
Limón, A. G. M., Herrera-Muñoz, J., Gutiérrez‐Sagal, R., & Ulloa‐Aguirre, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00421-5 · Cited by 43
Williams, M. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.06.001 · Cited by 43
Specific Inhibition of Elm1 Kinase Activity Reveals Functions Required for Early G 1 Events
Sreenivasan, A., Bishop, A. C., Shokat, K. M., & Kellogg, D. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6327-6337.2003 · Cited by 42
Self-citationMOLINARO, G., Carmona, A. K., Juliano, M. A., Juliano, L., Malitskaya, E., Yessine, M., Chagnon, M., LEPAGE, Y., Simmons, W. H., Boileau, G., et al. (2005) · Biochemical Journal · doi:10.1042/bj20040849 · Cited by 42
Holleran, J. L., Egorin, M. J., Zuhowski, E. G., Parise, R. A., Musser, S. M., & Pan, S. (2003) · Analytical Biochemistry · doi:10.1016/j.ab.2003.08.030 · Cited by 41
SUN, H. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.029 · Cited by 37
Zhao, X., Bondeva, T., & Balla, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14642 · Cited by 33
Chen, P., Norris, D. J., Das, J., Spergel, S. H., Wityak, J., Leith, L. W., Zhao, R., Chen, B., Pitt, S., Pang, S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.093 · Cited by 33
p38 Map Kinase Substrate Specificity Differs Greatly for Protein and Peptide Substrates
Hawkins, J. C., Zheng, S. G., Frantz, B., & LoGrasso, P. V. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2005 · Cited by 31
Cloning and Characterization of Xenopus Rsk2, the Predominant p90 Rsk Isozyme in Oocytes and Eggs
Bhatt, R. R., & Ferrell, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006386200 · Cited by 29
PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues
Abbott, B. M., & Thompson, P. E. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.043 · Cited by 28
Suer, S., Sickmann, A., Meyer, H. E., Herberg, F. W., & Heilmeyer, L. M. G. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02089.x · Cited by 24
Assay for IκB Kinases Using an in Vivo Biotinylated IκB Protein Substrate
Wisniewski, D., LoGrasso, P. V., Calaycay, J. R., & Marcy, A. I. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4287 · Cited by 22
Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR
Bilodeau, M. T., Cunningham, A. M., Koester, T. J., Ciecko, P. A., Coll, K. E., Huckle, W. R., Hungate, R. W., Kendall, R. L., McFall, R. C., Mao, X., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00485-2 · Cited by 19
A Tyrphostin-Derived Inhibitor of Protein Tyrosine Kinases: Isolation and Characterization
Ramdas, L., Obeyesekere, N., McMurray, J. S., Gallick, G. E., Seifert, W. E., & Budde, R. J. A. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.9969 · Cited by 10
Köhler, K., Lellouch, A. C., Vollmer, S., Stoevesandt, O., Hoff, A., Peters, L., Rogl, H., MALISSEN, B., & Brock, R. E. (2005) · ChemBioChem · doi:10.1002/cbic.200400241 · Cited by 8
Cited by
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., Loewith, R., Stokoe, D., Balla, A., Toth, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.035 · Cited by 1,174
Self-citationQuantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H., & Peterson, J. R. (2011) · Nature Biotechnology · doi:10.1038/nbt.2017 · Cited by 919
Potential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
Metadata
- Authors
- Knight, Z. A., & Shokat, K. M.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 12
- Issue
- 6
- Pages
- 621-637
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W2117022661
- Cited by
- 657
- References
- 113
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.